2001
DOI: 10.1006/bbrc.2001.5230
|View full text |Cite
|
Sign up to set email alerts
|

Neutrophils, Monocytes, and Dendritic Cells Express the Same Specialized Form of PSGL-1 as Do Skin-Homing Memory T Cells: Cutaneous Lymphocyte Antigen

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
40
0
3

Year Published

2003
2003
2016
2016

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 49 publications
(44 citation statements)
references
References 48 publications
1
40
0
3
Order By: Relevance
“…Induced expression of FUT7 is then stabilized by progressive demethylation of selected additional regulatory elements (including the minimal promoter region), as observed in TEM showing partial demethylation corresponding to the known subfraction of TEM-expressing FUT7. Ex vivo monocytes showed the most widespread demethylation within the FUT7 gene correlating to a constitutive expression of CLA (53). Interestingly, monocytes seem to start transcription further upstream, suggesting that the CNS, which acts as an enhancer in T cells, may drive expression of a monocyte-specific transcript, possibly even independently of the minimal promoter.…”
Section: Discussionmentioning
confidence: 99%
“…Induced expression of FUT7 is then stabilized by progressive demethylation of selected additional regulatory elements (including the minimal promoter region), as observed in TEM showing partial demethylation corresponding to the known subfraction of TEM-expressing FUT7. Ex vivo monocytes showed the most widespread demethylation within the FUT7 gene correlating to a constitutive expression of CLA (53). Interestingly, monocytes seem to start transcription further upstream, suggesting that the CNS, which acts as an enhancer in T cells, may drive expression of a monocyte-specific transcript, possibly even independently of the minimal promoter.…”
Section: Discussionmentioning
confidence: 99%
“…Although other mononuclear cells than T cells such as monocytes and dendritic cells can express CLA [19], lymphocytes expressing CLA comprised 25% of the lesion cells. This number is much lower than that observed in psoriasis, where CLA-positive cells account for up to 90% of lesion T cells [36].…”
Section: Discussionmentioning
confidence: 99%
“…The expression of CLA on normal human lymphocytes (and malignant leukocytes) directly correlates with the functional capacity of these cells to enter skin. [1][2][3][4][5][6][7][8][9][10] Although CLA is expressed on a subset of primitive human hematopoietic progenitor cells, [35][36][37][38] as well as on dendritic cells, monocytes, and neutrophils, 12 CLA expression is conspicuously up-regulated on effector lymphocytes and on malignant cells in patients with cutaneous inflammatory disease or leukemia/lymphoma, respectively. 1,5-10,14,47-50 Therefore, targeting the expression of CLA offers an attractive therapeutic approach for controlling leukocyte migration to skin.…”
Section: Discussionmentioning
confidence: 99%
“…[1][2][3][4][5][6][7][8][9][10] CLA is a sialyl Lewis X-like carbohydrate epitope displayed on the mucinlike molecule Pselectin glycoprotein ligand-1 (PSGL-1) recognized by the rat monoclonal antibody HECA-452. 2,11,12 CLA functions as the P-selectin ligand and the principal E-and L-selectin ligand on human skin-homing T cells; specifically, the presence of HECA-452 epitopes on PSGL-1 directly correlates with the capacity of skin-homing memory T cells (including skin-disease-related lymphocytes) to bind E-selectin, which is constitutively expressed on dermal microvasculature. 2,11,13 CLA-E-selectin binding interactions mediate lymphocyte trafficking to skin, and therefore, posttranslational glycosylations on skin-homing leukocytes represent a potential therapeutic target for controlling cutaneous tropism.…”
Section: Introductionmentioning
confidence: 99%